You are currently viewing a new version of our website. To view the old version click .
Journal: International Journal of Environmental Research and Public HealthVolume: 18Number: 6194
Article: Cost-Effectiveness Analysis of Dabrafenib Plus Trametinib and Vemurafenib as First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in China
  • Authors:
  • Tianfu Gao1,2,
  • Jia Liu1,2 and
  • Jing Wu1,2,*
Link: https://www.mdpi.com/1660-4601/18/12/6194

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.